Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment

American Journal of Drug and Alcohol Abuse

Volumn 30, Issue 2, 2004, Pages 237-249

  Cumberbatch, Zulema ^a   Copersino, Marc ^a   Stitzer, Maxine ^a   Jones, Hendrée ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Drug free modality; Methadone maintenance; Treatment modality

Indexed keywords

METHADONE;

ADDICTION SEVERITY INDEX; ADULT; ALCOHOLISM; ARTICLE; CITY; COCAINE DEPENDENCE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG ABUSE PATTERN; DRUG DETOXIFICATION; FEMALE; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT CARE; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; RATING SCALE; REINFORCEMENT; REINFORCEMENT BASED THERAPY; SOCIAL ASPECT; TREATMENT OUTCOME; UNITED STATES; URBAN AREA;

ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; METABOLIC DETOXICATION, DRUG; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; PSYCHOLOGY; URBAN POPULATION;

EID: 2942676628     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-120037376     Document Type: Article

References (29)

1. National Institute on Drug Abuse, Division of Epidemiology, Services and Prevention Research, Community Epidemiology Work Group (CEWG). Epidemiologic Trends in Drug Abuse: Volume I: Highlights and Executive Summary. Rockville, MD: DHHS Pub. No. (NIH) 014916A, 2001.
2. Maryland State Office of the Lieutenant Governor. Drug Treatment Task Force Final Report, Blueprint for Change: Expanding Access to and Increasing the Effectiveness of Maryland's Drug and Alcohol Treatment System. State of Maryland, 2001.
3. Baltimore Substance Abuse Systems Inc., On-line: http://www.bsasinc. org/bsas.htm (accessed May 2002).
4. Substance Abuse and Mental Health Services Administration (SAMHSA) of the U.S. Department of health human services. Substance abuse treatment facility locator on-line. http://www.findtreatment. samhsa.gov/ (accessed May 2002).
5. Dole VP, Nyswander ME. A medical treatment for diacetylmorphine (heroin) addiction. J Am Med Assoc 1965; 193:646-650.
6. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav 1997; 11(4):261-278.
7. Simpson DD, Joe GW, Brown BS. Treatment retention and follow-up outcomes in the drug abuse treatment outcome study. Psychol Addict Behav 1997; 11(4):294-307.
8. Brands B, Blake J, Marsh D. Changing patient characteristics with increased methadone maintenance availability. Drug Alcohol Depend 2002; 66(1):11-20.
9. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. J Am Med Assoc 1989; 261:561-565.
10. Caplehom JR, Dalton MS, Cluff MC, Petrenas AM. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994; 89(2):203-209.
11. Hubbard RL, Rachal JV, Craddock SG, Cavanaugh ER. Treatment Outcome Prospective Study (TOPS): Client characteristics and behaviors before, during, and after treatment. In: Tims FM, Ludford JP, eds. Drug Abuse Treatment Evaluation: Strategies, Progress, and Prospects. NIDA Research Monograph. Vol. 51. Rockville, MD: U.S. Department of Health and Human Services, 1984:42-68.
12. Farré M, Mas A, Torrens M, Moreno V, Camí J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend 2002; 65(3):283-290.
13. Simpson DD, Joe GW, Broome KM, Hiller ML, Knight K, Rowan-Szal GA. Program diversity and treatment retention rates in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav 1997; 11(4):279-293.
14. Koester S, Anderson K, Hoffer L. Active heroin injectors' perceptions and use of methadone maintenance treatment: cynical performance or self-prescribed risk reduction? Subst Use Misuse 1999; 34(14):2135-2153.
15. Schütz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend 1994; 36(2):129-138.
16. Gruber K, Chutuape MA, Stitzer ML. Reinforcement-based intensive outpatient treatment for inner city opioid abusers: a short-term evaluation. Drug Alcohol Depend 2000; 57(3):211-223.
17. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9(3):199-213.
18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press, Inc., 1996.
19. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New Engl J Med 2000; 343(18):1290-1297.
20. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc., 1997.
21. Etheridge RM, Hubbard RL, Anderson J, Craddock SG, Flynn PM. Treatment structure and program services in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav 1997; 11(4):244-260.
22. Hser YI, Anglin MD, Grella CE, Longshore D, Prendergast ML. Drug treatment careers: a conceptual framework and existing research findings. J Subst Abuse Treat 1997; 14(6):543-558.
23. Malcolm R, Roberts JS, Wang W, Myrick H, Anton RF. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol 2000; 22(3):159-164.
24. Richman A, Smart RG. After how many detoxications is rehabilitation probable? Drug Alcohol Depend 1981; 7(3):233-238.
25. Chermack ST, Roll J, Reilly M, Davis L, Kilaru U, Grabowski J. Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug Alcohol Depend 2000; 59(1):43-49.
26. Sherman MF, Bigelow GE. Validity of patients' self-reported drug use as a function of treatment status. Drug Alcohol Depend 1992; 30(1):1-11.
27. McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O'Brien CP. Problem-service 'matching' in addiction treatment. A prospective study in 4 programs. Arch Gen Psychiatry 1997; 54(8):730-735.
28. Miller WR, Zweben A, DiClemente CC, Rychtarik RG. Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. National Institute on Alcohol Abuse and Alcoholism (NIAAA) Project MATCH Monograph Series. Vol. 2. Rockville, MD: DHHS Pub., No. (ADM) 1892-1894, 1992.
29. Higgins ST, Alessi SM, Dantona RL. Voucher-based incentives; a substance abuse treatment innovation. Addict Behav 2002; 27(6):887-910.